STOCKHOLDERS AGREEMENT dated as of January 17, 2003 by and among ARENA PHARMACEUTICALS, INC., BIOTECHNOLOGY VALUE FUND, L.P., BIOTECHNOLOGY VALUE FUND II, L.P., BVF INVESTMENTS, L.L.C., BVF PARTNERS L.P., BVF INC. and INVESTMENT 10, L.L.C.Stockholders Agreement • January 21st, 2003 • Arena Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
This STOCKHOLDERS AGREEMENT dated as of January 17, 2003 (this "Stockholders Agreement") is made and entered into by and among Arena Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Biotechnology Value Fund, L.P., a Delaware limited partnership, Biotechnology Value Fund II, L.P., a Delaware limited partnership, BVF Investments, L.L.C., a Delaware limited liability company, BVF Partners L.P., a Delaware limited partnership, and BVF Inc., a Delaware corporation ("BVF"), and Investment 10, L.L.C., an Illinois limited liability company (each a "Stockholder" and, collectively, the "Stockholders").
